$3.27
+0.93%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$3.25
From 52W high−84.47%
Volume510862.00
Market cap$231.66M
P/E (TTM)—
P/S (TTM)388.2x
Div yield—
Key dataSep 18, 2026
Open
$3.25
From 52W high
−84.47%
Volume
510862.00
Market cap
$231.66M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−28.6x
P/E (TTM)
—
RSI (14)
44.6
MomentumView details →
1D Return
+0.93%
YTD Return
−73.01%
Similar companies
Latest newsMore news →
YD Bio Limited announced its unaudited financial results for the six months ended June 30, 2026.20d agoYD Bio, YD Bio US, EG BioMed US, and Numia Health launched a six-month pilot collaboration to evaluate a cross-border clinical workflow for physician-ordered, blood-based cancer testing for patients in British Columbia, Canada.54d agoYD Bio's affiliate EG BioMed US obtained out-of-state clinical laboratory licenses in Rhode Island and Pennsylvania, expanding its U.S. laboratory footprint to 46 states for DNA-methylation early cancer detection operations.80d ago